RICHMOND, Va. and RENO, Nev., Jan. 26,RICHMOND, Va., Jan. 7, 2026 /PRNewswire/ -- Alps Dx today announced its official launch as an innovative diagnostics tooling and automation company focused on improving the speed, safety, and scalability of oral fluid drug testing and beyond. The company enters the market with a leadership team of industry veterans and a clear commitment to addressing longstanding inefficiencies in pre-analytical workflows that have limited the adoption and reliability of oral fluid testing across clinical and forensic settings.

"Oral fluid testing has long offered the potential for a more accessible and patient-friendly approach to toxicology. Despite that promise, laboratories have continued to struggle with manual and inconsistent pre-analytical processes that require multiple handling steps and create delays, variability, and operational strain," said Les Edinboro, co-founder and Chief Scientific Officer. "The founders of Alps Dx identified this gap as a critical barrier to quality and throughput and formed the company to introduce a connected, automated approach that rethinks how oral fluid moves from collection to analysis."

Ali Safavi, President, CEO, and co-founder, described the vision as follows: "Alps Dx will transform drug testing as we know it – replacing outdated, uncomfortable, and complicated sample collection with a clean, automated, and efficient oral fluid solution that removes major chain-of-custody obstacles and streamlines the entire process while eliminating user and process errors."

The leadership team brings a combination of scientific, engineering, and operational expertise shaped by decades of direct experience in laboratory environments. The company is led by President and Chief Executive Officer Ali Safavi, a visionary serial entrepreneur known for advancing efficiency and sustainability in laboratory operations. Chief Scientific Officer Les Edinboro brings deep scientific toxicology experience from his tenure as Executive Director of Toxicology at one of the world's largest diagnostics organizations. They are joined by diagnostics executive Greg Ourednik and engineering innovator Brian Sorel, rounding out a team with hands-on understanding of laboratory challenges and the technical capability to build practical, scalable solutions.

At the center of the company's mission is the goal of improving lives by making oral fluid drug testing more accessible for businesses, employees, and consumers, while enabling laboratories to adopt faster, safer, and more scalable automated workflows. To achieve this vision, Alps Dx is developing a suite of products that automate the sample journey across the pre-analytical continuum, including the application platform, collection kits, instruments, consumables, software, and integrated applications designed to function as a unified system.

Alps Dx plans to introduce a connected portfolio in 2026 that includes instruments for automated sample processing, enhanced filtration tools for oral fluid, a guided workflow software platform, an intuitive mobile application for sample identification and tracking, and a next-generation oral fluid collection device currently in development. Together, these solutions are designed to reduce manual handling, improve sample integrity, and allow laboratories to operate with greater confidence and efficiency.

The company will soon debut its first automated instrument, developed in collaboration with a global leader in laboratory robotics. Additional details regarding the initial showcase and commercial launch will be shared in a forthcoming announcement.

About Alps Dx

Alps Dx develops automated and connected technologies that modernize the sample collection and pre-analytical oral fluid continuum for drug testing and beyond. The company's portfolio includes purpose-built instruments, consumables, workflow software, and applications that help laboratories increase efficiency, protect patient outcomes, and scale operations. Alps Dx is headquartered in Richmond, Virginia. For more information, visit alpsdx.com.

SOURCE Alps Dx 2026 /PRNewswire/ -- Alps Dx and Hamilton Company today announced the showcase of Alps Dx Atelier, an automated system designed to streamline and standardize the preanalytical stage of oral fluid drug testing. This instrument will be showcased at the Alps Dx booth at the SLAS 2026 conference in Boston, Mass. Built on the Hamilton MICROLAB® STARlet liquid handling platform, Alps Dx Atelier integrates patented technologies, dedicated modules, consumables, and workflow software developed by Alps Dx specifically for oral fluid applications.

Preanalytical processing remains one of the most manual and variable steps in oral fluid testing. Many laboratories still rely on repetitive handling, workarounds, and inconsistent filtration that slow operations and compromise downstream instrument performance. Alps Dx Atelier was developed to address these challenges and to help laboratories improve sample quality, turnaround time, and overall operational efficiency.

Designed for the widely used FDA‑cleared collection device, Quantisal®, Alps Dx Atelier automates high‑friction tasks: sample barcode identification to support chain‑of‑custody tracking; decapping, removal, and processing of the Quantisal oral fluid collection device; automated insertion of the Alps Dx Xpressor filter for clearer samples; and precise tube capping or recapping. Optional modules add aliquoting and HEPA filtration for more complex workflows.

By reducing manual handling and standardizing every critical step, the system minimizes variability, eases staffing pressure, and frees teams for higher‑value work. Automated filtration with the Xpressor filter yields cleaner, more consistent samples, helping reduce downstream maintenance on analytical instruments. A guided workflow and scalable configuration let clinical and forensic laboratories expand capacity while protecting reproducibility.

"We built Alps Dx Atelier to address a critical gap in toxicology and forensic workflows for oral fluid drug screening. Oral fluid testing could not fully reach its potential without a more efficient and standardized preanalytical process," said Ali Safavi, President, CEO, and co-founder of Alps Dx. "By combining Hamilton's proven liquid handling architecture with the oral fluid-specific design elements developed by our team, we are providing laboratories with a precise and dependable solution that supports quality and accelerates time to result."

"We are excited to collaborate with Alps Dx and its experienced team of industry veterans to bring a purpose-built automated solution to one of the most challenging areas of oral fluid testing," said Michael Mouradian, Vice President of Scientific Strategy and Market Development, Hamilton Company. "The MICROLAB STARlet platform provides a proven foundation for precision, accuracy, flexibility, and reproducible automation. By integrating the platform with Alps Dx oral fluid-specific technologies and workflow design, we are enabling laboratories to standardize preanalytical processing, reduce manual burden, and operate with greater confidence and efficiency. Together, Alps Dx and Hamilton are advancing the modernization of the oral fluid testing continuum."

About Alps Dx
Alps Dx develops automated and connected technologies that modernize the preanalytical oral fluid continuum for drug testing and beyond. The company's portfolio includes purpose-built instruments, consumables, workflow software, and applications that help laboratories increase efficiency, protect patient outcomes, and scale their operations. Alps Dx is headquartered in Richmond, Virginia. For more information, visit alpsdx.com.

About Hamilton
For more than 75 years, Hamilton Company has been a global life sciences leader in the design and manufacturing of precision measurement devices, automated liquid handling platforms, and sample management solutions. Headquartered in Reno, Nevada, with key manufacturing and R&D affiliates in Bonaduz, Switzerland, Franklin, Massachusetts, and Timisoara, Romania, Hamilton serves the scientific community through a robust network of sales and support offices worldwide.

Hamilton's expertise spans across liquid handling, process analytics, robotics, and automated storage, providing the foundational tools necessary for groundbreaking scientific research and clinical discovery. By combining the best-quality materials with skilled workmanship and a lifelong commitment to ISO 9001-certified precision, Hamilton ensures the highest level of performance and reliability. Hamilton remains dedicated to driving innovation and satisfying the evolving needs of laboratories across the globe, maintaining a steadfast focus on quality and customer success.

SOURCE Alps Dx